当前位置：
X-MOL 学术
›
J. Nat. Prod.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Non-Insulin-Based Drug Entities Used to Treat Diabetes Type 2 Disease (T2DM), Based on Natural Products from All Sources
Journal of Natural Products ( IF 5.1 ) Pub Date : 2024-02-16 , DOI: 10.1021/acs.jnatprod.3c00886 David J. Newman 1
Journal of Natural Products ( IF 5.1 ) Pub Date : 2024-02-16 , DOI: 10.1021/acs.jnatprod.3c00886 David J. Newman 1
Affiliation
|
Diabetes type 2 (T2DM) is the non-insulin-linked disease that is now becoming a major problem not only in the West but also in Asia (particularly in China and close geographic areas). Unlike the childhood onset diabetic disease (T1DM), which is effectively due to lack of insulin production and is maintained by insulin injection, T2DM is best thought of as an adult disease often being caused by what is now considered “metabolic syndrome” or the culmination of too many insults to the body, in particular obesity and its “coupled diseases” including heart problems. Its symptoms were described in ancient times not only in Europe but also in Asia and with later (1600s) anecdotal reports from South America. In all cases, the diagnostic was “sweet urine” due to the excretion of large amounts of glucose in the urine. This review covers the non-insulin agents approved from 1990 to 2021 from a historical aspect and discussions of the latest agents and can be considered an extension of the author’s previous drug source reviews, but this time concentrating on nominally one disease entity, though metabolic syndrome is a collection of ailments.
更新日期：2024-02-16
京公网安备 11010802027423号